|
|
||||||||
Clinical Chemistry, Vol 22, 1729-1731, Copyright © 1976 by American Association for Clinical Chemistry
I Kaufmann-Raab, HG Jonen, E Jahnchen, GF Kahl and U Groth
Acetaminophen, p-aminophenol, and oxyphenbutazone interfere with the glucose oxidase/peroxidase method for glucose. Structurally related compounds that lack a free phenolic hydroxyl group (acetanilide, aniline, and phenylbutazone) do not interfere. During the analytical procedure acetaminophen is consumed. One mole of acetaminophen leads to an apparent loss of four moles of glucose. The hexokinase/glucose-6- phosphate dehydrogenase method (Boehringer Hexokinase method) is not affected by these substances.
The following articles in journals at HighWire Press have cited this article:
![]() |
K. Dungan, J. Chapman, S. S. Braithwaite, and J. Buse Glucose Measurement: Confounding Issues in Setting Targets for Inpatient Management Diabetes Care, February 1, 2007; 30(2): 403 - 409. [Full Text] [PDF] |
||||
![]() |
B. S. Karon, T. M. Daly, and M. G. Scott Mechanisms of dopamine and dobutamine interference in biochemical tests that use peroxide and peroxidase to generate chromophore Clin. Chem., January 1, 1998; 44(1): 155 - 160. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |